David LLorente

CEO & Co-Founder @Narrativaai / Agentic AI platform

[David LLorente @dllorent]

Congratulations, Sam! 👏👏

[Narrativa @NarrativaAI]

🌿 Big congratulations to Samantha Eells, our Key Account Manager, for completing the Sustainability Certificate program at UCLA Extension.

We are proud to have you on the team, Sam! 👏

🔗 More details: https://t.co/qmoxfMLoTD

#LifeSciences #Pharma #Sustainability

[Narrativa @NarrativaAI]

🔬 $1M to $4M in CRO fees alone for a Phase I trial.

Much of it goes to infrastructure, not data.

The CRO model is being pushed to evolve and agentic AI enables faster execution. Not bigger teams. Smarter systems.

See how 👇

https://t.co/W5MmhFVdmF

[David LLorente @dllorent]

Excited to see this podcast come to life!! Congratulations, Jennifer. This series does a great job of breaking down what actually matters and what is worth your time. ⤵️

[Narrativa @NarrativaAI]

🎙️ New podcast alert: New, Innovative & Crazy about AI.

What is truly shaping the future of AI and what is just hype? Each episode breaks down what is new, what is innovative, and what might be just… a little crazy.

🚀 Watch the first episodes. ⬇️

https://t.co/PMu9V5CPL8

[David LLorente @dllorent]

We know a thing or two about AI, and we have applied that experience to build the AI Confidence Training Program. If AI still feels confusing or overwhelming, start here. 👇

[Narrativa @NarrativaAI]

🎓 With 10 years building intelligent systems across industries, we know people need clarity, not hype.

That is why we are launching our AI Confidence Training Program. Learn the fundamentals, real world use cases, and best practices. No technical background required.

Complete it and receive your diploma. 👩‍🎓

https://t.co/JFwiUMyknN

[David LLorente @dllorent]

Huge congratulations, Jennifer!! Very well-deserved recognition of your work in life sciences.

[Narrativa @NarrativaAI]

👇 Some news we’re genuinely proud of.

Our president, Jennifer Bittinger, joins the CDISC Board of Directors for a three year term.

More details in the full article ⬇️

#CDISC #ClinicalResearch

https://t.co/x6ACoYRkfX

[BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech]

TechBio AI valuations, hype or real?

For companies using AI to make clinical development cheaper and faster, it looks a lot less like hype.

They are front-loading success - especially from Phase I to II, where most capital gets incinerated.

>PhI to II success jumps to ~80% (~40-65% historic)
>PhII still hard, but meaningfully better than baseline
>Later stages show smaller deltas, as expected

While we often value companies off peak sales and lifetime revenue, is not only about peak sales.

How much capital and time you spend to find out if something works matters as well.

AI helps:
>pick better targets,
>run tighter trials,
>kill bad programs faster,
>reach POC sooner,

Then you cut burn, shorten timelines, and improve capital recycling = higher rNPV and IRR!!!!

So who buys one of these AI clinical efficiency enhancement stories?

>mid-cap pharma that needs pipeline but cannot afford repeated Phase II misses
>big pharma BD looking for de-risked assets with cleaner early data
>platform acquirers who want a repeatable engine, not a one-off drug
>strategics facing patent cliffs, where speed matters

🤔The question is do one of the buyers above make a traditional M&A bid? Or do they wind up signing lucrative collaboration or subscription models and the ultimate buyer is one of the tech health divisions (think Google, OpenAI, Meta, etc) that can integrate the backend data and use it to further drive enhancement?

https://t.co/MQzk9xTQ6x

[David LLorente @dllorent]

If you are heading to Orlando for #SCOPE2026, send Jennifer Bittinger a message to set up a quick chat. ⬇️

[Narrativa @NarrativaAI]

☀️ Orlando, we are coming.

Our President, Jennifer Bittinger, will be at #SCOPE2026 and available to connect.

Send us a message to meet up. 📩

#ScopeSummit #LifeSciences #Pharma #ClinicalResearch

[Narrativa @NarrativaAI]

🔮 2026 is here and AI in Pharma is moving fast.

Less hype, more focus on what actually scales: AI agents, verticalization, and real ROI.

Here is what our AI experts at Narrativa see coming. 👇

#AIinPharma #LifeSciences #AgenticAI

https://t.co/8u7dZXJCQt

[David LLorente @dllorent]

@NarrativaAI Agentic AI is making a real difference for regulatory teams, and this is just the beginning. Let’s see what agentic AI delivers in 2026. 👏

[David LLorente @dllorent]

Happy to connect during J.P. Morgan Healthcare Week in San Francisco. Please feel free to reach out. 📩

[Narrativa @NarrativaAI]

🔜 J.P. Morgan Healthcare Week is just around the corner. We will be in San Francisco all week connecting on how AI is moving from experimentation to execution in healthcare.

Our President, Jennifer Bittinger, and CEO, @dllorent, will be there and happy to chat.

Reach out on X or by email. 📩 #JPM2026

[David LLorente @dllorent]

Lisa is absolutely right. We talk a lot about metrics, but what really matters are those moments when a patient reaches a potential cure.

[Narrativa @NarrativaAI]

🗣️ "Transformation is hard, but every time a patient gains access to a potential cure, it’s worth it."

2⃣ Continuing our Advisory Board series with Lisa La Luna on AI and patient advocacy in clinical research.

#Pharma #AI

https://t.co/UypKePni4K

[David LLorente @dllorent]

@NarrativaAI In pharma and biotech, you simply can’t take risks. Any move toward clearer guidance in AI is worth watching.

[David LLorente @dllorent]

@NarrativaAI Welcome aboard! We are happy to have you.

[Narrativa @NarrativaAI]

✍️ Not everything you read is written by AI. Or is it?

In 2024, AI-generated articles temporarily surpassed human ones, according to https://t.co/zh7MJKk4L2. But the future isn’t AI or human: it’s human + AI.

Discover more insights here. 👇
https://t.co/hAQgiAkrCn

[David LLorente @dllorent]

Few people know the pharmaceutical industry like David Evans. His experience working closely with regulators gives him a unique perspective, and it’s a pleasure listening to him share it.

[Narrativa @NarrativaAI]

🗣️ “Pharma regulatory bodies are embracing the use of AI internally.”

🚀 We’re launching a new series of interviews with our Advisory Board! First up: David Evans on AI in pharma & healthcare.

#Pharma #AI

🔗 https://t.co/BAERLqwlYc

[David LLorente @dllorent]

Proud of what we’ve accomplished, but even more excited for what’s ahead. Not every year a company turns 10, and the secret is simple: surround yourself with a great team. Thank you to everyone who’s been part of the journey!

[Narrativa @NarrativaAI]

🎉 Narrativa is celebrating 10 years!

From media to pharma, we've used #GenerativeAI to help teams move faster and smarter.

👏 Huge thanks to our clients, partners, shareholders, and the #TeamNarrativa. 👏

https://t.co/mqeHhi0fhy

[David LLorente @dllorent]

Our main goal is to make content creation easier, faster, and more consistent for every team. The features of Narrativa® Navigator make that possible, and open the door to much more.

[Narrativa @NarrativaAI]

🚀 Everything you can do with Narrativa® Navigator. ⬇️⬇️

✅ Automated content generation at scale
✅ Multilingual support for global reach
✅ Easy to integrate into your tools
✅ Consistency and quality across every piece

#GenerativeAI #ContentAutomation

[David LLorente @dllorent]

They’re both Argentinian media outlets, already strong in their home market. Now, Infobae and El Cronista lead the media rankings in Mexico. With Narrativa® Navigator, they’ve expanded to new markets—faster and without losing quality. Congratulations to both teams!

[Narrativa @NarrativaAI]

🚀 From Argentina to the top of Mexico’s media charts: AI-powered journalism in action.

📰 Infobae & El Cronista, now Mexico’s most-read outlets, rely on Narrativa® Navigator to scale their content production.

⚡️ Human + AI = smarter journalism.

https://t.co/KajfI8TZja

[David LLorente @dllorent]

Many of our clients ask us whether it’s better to host their own LLM or use a managed solution. It’s an important choice that affects privacy, control, cost, and speed, so we’ve put together this simple guide to help clarify the pros and cons. Hope it’s helpful!

[Narrativa @NarrativaAI]

🤔 Self-host your LLM or use a managed one (like GPT-4 via AWS)?

We made a simple guide to help you decide — with clear pros, cons, and a comparison table you can share with your team.

🚀 Find the best fit for your use case.

#LLM #GenAI

https://t.co/w2f0yUrNXR

[David LLorente @dllorent]

It was a pleasure to be part of the conversation and share @NarrativaAI’s story.

[Narrativa @NarrativaAI]

📸AI took center stage yesterday in Madrid, where @Emprendedores hosted an event with leading voices in business and SME innovation.

📖 @dllorent joined a conversation on real-world AI use, as Narrativa was featured in a special edition for its role in AI-driven innovation.